1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
申请人:Actelion Pharmaceuticals Ltd.
公开号:US09169270B2
公开(公告)日:2015-10-27
The present invention relates to 1-phenyl-substituted heterocyclyl derivatives of the formula (I),
wherein Y, Z, R1, R2, R3 and R4 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.
本发明涉及公式(I)中的1-苯基取代杂环基衍生物,其中Y、Z、R1、R2、R3和R4如描述中所述,并且它们作为前列腺素受体调节剂的用途,特别是作为前列腺素D2受体调节剂,在治疗各种前列腺素介导的疾病和疾病中使用,以及包含这些化合物的制药组合物和它们的制备方法。